NDC 87625-101 - SurviveX Travel Med Kit
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 87625-101
- Manufacturer
- Intent Brands LLC
- Effective date
- 2026-05-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SurviveX Travel Med Kit - Intent Brands LLC | Intent Brands LLC | 2026-05-07 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AXIM DM Max | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | VIVUNT PHARMA LLC | 0e7424ea-461f-5ead-e063-6294a90a41b6 | 2024-01-05 | Warnings | M012 |
| AXIM Night Time - Liquid | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | VIVUNT PHARMA LLC | 0e740063-80d5-c48b-e063-6394a90a3b30 | 2024-01-05 | Warnings | M012 362O9ITL9D |
| AXIM DayTime - Liquid | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | VIVUNT PHARMA LLC | 0e742e10-daea-6443-e063-6294a90ab5af | 2024-01-05 | Warnings | M012 362O9ITL9D |
| Diphenhydramine HCl | DIPHENHYDRAMINE HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | 3c3e0dc8-cddd-4f46-9b68-19bac00c07cc | 2024-01-05 | Warnings | M012 TC2D6JAD40 |
| Diphenhydramine HCl | DIPHENHYDRAMINE HCL | A-S Medication Solutions | fa12a5a8-bf2d-4991-9d54-9c519e8e04cd | 2024-01-04 | Warnings | M012 TC2D6JAD40 |
| IBUPROFEN CA | IBUPROFEN | TARGET CORPORATION | 8e8684fa-095e-c6d6-e053-2a95a90a15b4 | 2024-01-03 | Warnings | 310965 WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | TARGET CORPORATION | 8e86ae68-7687-79d6-e053-2995a90ac274 | 2024-01-03 | Warnings | 310965 WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | TARGET CORPORATION | 8e8646fe-fd62-1662-e053-2a95a90a3008 | 2024-01-03 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | TARGET CORPORATION | 8e872c8d-28e2-cd49-e053-2995a90a469f | 2024-01-03 | Warnings | 310965 WK2XYI10QM |
| Ibuprofen Mini | IBUPROFEN MINI 200 MG | TARGET CORPORATION | c80426d9-e121-c24d-e053-2a95a90acf2f | 2024-01-03 | Warnings | WK2XYI10QM |
| IBUPROFEN 200 MG | IBUPROFEN | Basic Drugs, Inc. | d3351d44-2078-3adc-e053-2995a90a3c8f | 2024-01-03 | Warnings | 310965 WK2XYI10QM |
| LORATADINE ALLERGY RELIEF 10mg | LORATADINE | YYBA CORP | dcb63e1b-d499-2e84-e053-2995a90af5c7 | 2024-01-03 | Warnings | 311372 7AJO3BO7QN |
| ALLERGY RELIEF 10mg | LORATADINE | YYBA CORP | 6103cf98-40b1-4d27-8eb7-6f6a06949730 | 2024-01-03 | Warnings | 311372 7AJO3BO7QN |
| NASAL DECONGESTANT PE 10mg | PHENYLPHRINE HCL | YYBA CORP | 05824fc4-ef3f-4ebb-b601-252f76ad60ef | 2024-01-03 | Warnings | M012 04JA59TNSJ |
| Loratadine | LORATADINE | Tenshi Kaizen Pvt Ltd | c20b91e0-ef92-6f2f-e053-2a95a90a2a36 | 2024-01-02 | Warnings | 7AJO3BO7QN |
| LORATADINE | LORATADINE | CVS PHARMACY, INC | 7ed2aec0-4da7-4edc-9998-b96c67c82738 | 2024-01-02 | Warnings | 7AJO3BO7QN |
| LORATADINE | LORATADINE | Strides Pharma Inc | 16ab6610-ac99-4714-848d-9377c6bca459 | 2024-01-02 | Warnings | 7AJO3BO7QN |
| LORATADINE | LORATADINE | Strides Pharma Inc | a54cdbe9-32ec-45ca-948f-9cefbb8e3cbf | 2024-01-02 | Warnings | 7AJO3BO7QN |
| LORATADINE | LORATADINE | Tenshi Kaizen Pvt Ltd | c20b916d-7dd0-1a56-e053-2995a90a3c1b | 2024-01-02 | Warnings | 7AJO3BO7QN |
| Anti-Itch Cream | DIPHENHYDRAMINE HYDROCHLORIDE 2%, ZINC ACETATE 0.1% | Trifecta Pharmaceuticals USA, LLC. | 44d17651-a31b-64ca-e054-00144ff8d46c | 2024-01-02 | Warnings | TC2D6JAD40 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.